Beijing Science Sun Pharmaceutical Co., Ltd. (SHE:300485)
China · Delayed Price · Currency is CNY 9.63
-0.41 (-4.08%)
May 20, 2026, 2:15 PM CST
SHE:300485 Revenue
Beijing Science Sun Pharmaceutical had revenue of 90.44M CNY in the quarter ending March 31, 2026, a decrease of -2.27%. This brings the company's revenue in the last twelve months to 402.62M, up 0.79% year-over-year. In the year 2025, Beijing Science Sun Pharmaceutical had annual revenue of 404.72M, down -2.82%.
Revenue (ttm)
402.62M
Revenue Growth
+0.79%
P/S Ratio
12.01
Revenue / Employee
823.36K
Employees
489
Market Cap
4.84B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 404.72M | -11.76M | -2.82% |
| Dec 31, 2024 | 416.48M | -60.09M | -12.61% |
| Dec 31, 2023 | 476.57M | -257.98M | -35.12% |
| Jan 1, 2023 | 734.55M | -316.26M | -30.10% |
| Jan 1, 2022 | 1.05B | -43.42M | -3.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ZhuZhou QianJin Pharmaceutical Co.,Ltd | 3.59B |
| Jianmin Pharmaceutical Group | 3.35B |
| Hunan Fangsheng Pharmaceutical | 1.79B |
| Fuan Pharmaceutical (Group) | 1.74B |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 1.68B |
| Tianjin Lisheng Pharmaceutical | 1.35B |
| Bide Pharmatech | 1.35B |
| Beijing Beilu Pharmaceutical | 1.24B |